IP Verse

Treatment Of Cataplexy - EP2968208

The patent EP2968208 was granted to Aerial Biopharma on Jul 20, 2022. The application was originally filed on Mar 12, 2014 under application number EP14778088A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2968208

AERIAL BIOPHARMA
Application Number
EP14778088A
Filing Date
Mar 12, 2014
Status
Opposition Rejected
Aug 1, 2025
Grant Date
Jul 20, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZApr 20, 2023ADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2009312416
DESCRIPTIONUS5705640
DESCRIPTIONUS5756817
DESCRIPTIONUS5955499
DESCRIPTIONUS6140532
INTERNATIONAL-SEARCH-REPORTUS6204245
INTERNATIONAL-SEARCH-REPORTWO2006133393
INTERNATIONAL-SEARCH-REPORTWO2011005473
OPPOSITIONWO2006133393
OPPOSITIONWO2011055965
SEARCHUS2009312416

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy", ClinicalTrials.gov; NCT01681121, (20120907), ClinicalTrials.gov; NCT01681121, URL: https://classic.clinicaltrials.gov/ct2/show/NCT01681121, (20240411), XP093150768-
OPPOSITION- Anonymous, "Measures of Central Tendency", Anonymous, James E De Munt, Basic Statistics and Pharmaceutical Statistical Applications second edition, Chapman & Hall/CRC, (20060101), pages 69 - 93, ISBN 978-0-8493-3799-4, XP093133554-
OPPOSITION- Bogan Rk, Nt Feldman, A Lankford, Ma Khayrallah, "A DOUBLE BLIND. PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY OF THE EFFICACY AND SAFETY OF ADX-N05 FOR THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS IN ADULT SUBJECTS WITH NARCOLEPSY", JOURNAL OF SLEEP AND SLEEP DISORDERS RESEARCH - VI. Sleep Disorders - Hypersomnia, (20130101), vol. 36, no. Abstract Supplement, pages A257 - A257, XP093150770-
OPPOSITION- Garde Damian, "Aerial Biopharma Announces Positive Results for ADX-N05 202; A Phase 2b trial for Narcolepsy", BIOTECH, (20131001), BIOTECH, URL: https://www.fiercebiotech.com/biotech/double-autoimmune-acquisitions-century-eliem-both-pick-peers, (20240411), XP093150775-
OPPOSITION- Myers Calisha, "Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy", BIOTECH, (20090513), BIOTECH, URL: https://www.fiercebiotech.com/biotech/double-autoimmune-acquisitions-century-eliem-both-pick-peers, (20240411), XP093150765-
OPPOSITION- Frederick Dorey, "In Brief: The P Value: What Is It and What Does It Tell You?", Clinical Orthopaedics and Related Research, US , (20100801), vol. 468, no. 8, doi:10.1007/s11999-010-1402-9, ISSN 0009-921X, pages 2297 - 2298, XP055585419
OPPOSITION- Dauvilliers, Y. Arnulf, I. Mignot, E., "Narcolepsy with cataplexy", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20070210), vol. 369, no. 9560, doi:10.1016/S0140-6736(07)60237-2, ISSN 0140-6736, pages 499 - 511, XP005879778
OPPOSITION- O'brien Sheila F., Osmond Lori, Yi Qi‐long, "How do I interpret a p value?", Transfusion, US , (20151201), vol. 55, no. 12, doi:10.1111/trf.13383, ISSN 0041-1132, pages 2778 - 2782, XP093133550
OPPOSITION- Chad Ruoff, Todd J. Swick, Robert Doekel, Helene A. Emsellem, Neil T. Feldman, Russell Rosenberg, Gary Bream, Moise A. Khayrallah, Yuan Lu, Jed Black, "Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study", SLEEP, ALLEN PRESS, LAWRENCE, KS, US, US , (20160701), vol. 39, no. 7, doi:10.5665/sleep.5968, ISSN 0161-8105, pages 1379 - 1387, XP055768511
SEARCH[ ] - RICHARD K. BOGAN ET AL, "Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy", SLEEP MEDICINE, NL, (20150901), vol. 16, no. 9, doi:10.1016/j.sleep.2015.05.013, ISSN 1389-9457, pages 1102 - 1108, XP055300138 [ ] * the whole document *
SEARCH[ ] - SHANNON S SULLIVAN ET AL, "Emerging drugs for common conditions of sleepiness: obstructive sleep apnea and narcolepsy", EXPERT OPINION ON EMERGING DRUGS, UK, (20151002), vol. 20, no. 4, doi:10.1517/14728214.2015.1115480, ISSN 1472-8214, pages 571 - 582, XP055300177 [ ] * page 572, column r, paragraph 1 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents